HomeREGULATORY
REGULATORY

Pricing Predictability Could Crumble via Japanese CEA Introduction, Tada Frets at Chuikyo
(Oct.12.2017)

(from left) FPMAJ Chairman Masayo Tada, PhRMA Japan Executive Committee Chairman Patrik Jonsson, EFPIA Japan Director Heike Prinz at Chuikyo Meeting
The proposed introduction of some sort of cost-effective assessment (CEA) could lack consistency with Japan’s long-standing drug pricing system, wreaking havoc on predictability - a vital factor for research-intensive pharmaceutical companies, a Japanese drug industry leader said on October 11 ...
(LOG IN FOR FULL STORY)

News Calendar